Longitudinal Taxonomic and Predicted Functional Gut Microbiome Responses to Tirzepatide and Semaglutide: An Exploratory Secondary Analysis of the OMDOT-1 Randomized Controlled Trial
Diabetes, obesity & metabolism · 2026 Nov 8 · Morioka T, Miyaoka D, Nakatani S et
MH
By Maren Holt · Senior Reporter, GLP-1
Nov 7 19:00 ETSource: Diabetes, obesity & metabolism
From the source
Read at pubmed.ncbi.nlm.nih.govLongitudinal Taxonomic and Predicted Functional Gut Microbiome Responses to Tirzepatide and Semaglutide: An Exploratory Secondary Analysis of the OMDOT-1 Randomized Controlled Trial
Diabetes, obesity & metabolism · 2026 Nov 8 · Morioka T, Miyaoka D, Nakatani S et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/43000189/
